Early detection of cancer: Fluorophore-labeled cyclooxygenase-2 inhibitors for imaging of overexpression

November 7, 2013 by Edward Knaus
Early Detection of Cancer
Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer

Molecules that bind and illuminate proteins specific to tumor cells are key to detecting cancer as early as possible. The cyclooxygenase-2 (COX-2) enzyme is just such a protein, as the concentration of COX-2 is greater in cancer cells than in adjacent normal tissues. Therefore, attaching a suitable fluorescent label to a selective COX-2 inhibitor would be an effective strategy for the noninvasive detection of tumors in which COX-2 levels are elevated.

As they report in ChemMedChem, a collaboration led by Frank Wuest, Edward Knaus, and colleagues at the University of Alberta in Canada resulted in an important compound in which a 7-nitrobenzofurazan (NBD) fluorescent label is linked to the well-known anti-inflammatory drug celecoxib (celecoxib–NBD conjugate). Biological studies showed that this conjugate is a potent and of COX-2, a COX-2-specific biomarker for fluorescence imaging of cancer, and a useful optical probe for targeted imaging of COX-2 in cells and small animals, as well as for clinical imaging of tissues suitable for topical or endoluminal illumination, such as esophagus and colon.

"These results will be of interest to researchers and clinicians with specialization in the use of fluorescent biomarkers for the imaging and/or diagnosis of disease states in which the COX-2 isozyme is expressed, such as ," says Knaus. This work marks a significant step forward in efforts to facilitate the detection and diagnosis of cancer as early as possible.

Explore further: Study: Celecoxib can cause arrhythmias

More information: Fluorophore-Labeled Cyclooxygenase-2 Inhibitors for the Imaging of Cyclooxygenase-2 Overexpression in Cancer: Synthesis and Biological Studies, ChemMedChem, dx.doi.org/10.1002/cmdc.201300355

Related Stories

Study: Celecoxib can cause arrhythmias

January 15, 2008

U.S. medical researchers have determined the anti-inflammatory drug celecoxib (Celebrex) can adversely affect heart rhythm in fruit fly and rat models.

Fluorescent compounds make tumors glow

April 29, 2010

A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers.

Imaging inflammation in the living brain

September 30, 2011

Inflammation occurs in the human brain during illnesses such as Alzheimer's disease, Parkinson’s disease, stroke and traumatic brain injury. Now, a research team in Japan has developed a probe that can bind to the pro-inflammatory ...

Recommended for you

Light can 'heal' defects in some solar cells

May 24, 2016

A family of compounds known as perovskites, which can be made into thin films with many promising electronic and optical properties, has been a hot research topic in recent years. But although these materials could potentially ...

Researchers untangle disease-related protein misfolding

May 23, 2016

Though research on protein folding has progressed over the past few decades toward better understanding of human metabolism and the diseases associated with misfolding, important discoveries are still being made by teams ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.